IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.

MLA

Tang, Haiming, et al. “IRF8 May Be a Useful Marker for Blastic Plasmacytoid Dendritic Cell Neoplasm, Especially with Weak CD123 Expression.” Journal of Cutaneous Pathology, vol. 50, no. 7, July 2023, pp. 595–600. EBSCOhost, https://doi.org/10.1111/cup.14439.

APA

Tang, H., Panse, G., Braddock, D., Perincheri, S., Xu, M. L., & McNiff, J. M. (2023). IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression. Journal of Cutaneous Pathology, 50(7), 595–600. https://doi.org/10.1111/cup.14439

Chicago

Tang, Haiming, Gauri Panse, Demetrios Braddock, Sudhir Perincheri, Mina L Xu, and Jennifer M McNiff. 2023. “IRF8 May Be a Useful Marker for Blastic Plasmacytoid Dendritic Cell Neoplasm, Especially with Weak CD123 Expression.” Journal of Cutaneous Pathology 50 (7): 595–600. doi:10.1111/cup.14439.